InvestorsHub Logo
Followers 32
Posts 13008
Boards Moderated 0
Alias Born 08/29/2012

Re: imanjen13 post# 382813

Wednesday, 07/19/2023 2:16:42 AM

Wednesday, July 19, 2023 2:16:42 AM

Post# of 407422
I'm already on RECORD stating we could get the approval in the 1st calendar quarter of 2024.

Here ya go:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172267344

The midpoint period between your suggested dates the insufflation study was possibly submitted to get a PDUFA date would be April 16, 2023. If PDUFA date was established at that time, it is possible that the company will receive approval of its OxyContin ANDA as early as February 16, 2023(2024) if the usual 10 month waiting period applies.


MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News